KMLE
»çÀÌÆ® ¼Ò°³
°Ë»ö
°Ë»ö¾î Áö¿ì±â
´Ý±â
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
°í±Þ °Ë»ö ¼³Á¤
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú :
14
ÆäÀÌÁö:
5
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ȯÀÎÅ©·ÎÇȼÖÁ¤25mg
Zuclopenthixol Hydrochloride 29.55 mg
ȯÀÎÁ¦¾à
Àü¹®|»èÁ¦
0¿ø/1 °³
½ÃÄ«·Ñ¿¬Áúĸ½¶
Calcitriol 0.25 ¥ìg
ȯÀÎÁ¦¾à
Àü¹®|»èÁ¦
0¿ø/1 °³
ÆäÀ̳¯ÁÖ
Caroverine HCl 40
ȯÀÎÁ¦¾à
Àü¹®|»èÁ¦
0¿ø/2 °³
¶ôƾÁ¤
Lactobacillus Acidophilus Tyndalized Gr. 464 mg
ȯÀÎÁ¦¾à
ÀϹÝ|»èÁ¦
0¿ø/1 °³
ȯûȯ
Rehmannia Root 18.2 mg, Apricot Kernel 6.07 mg, Aurantii Fructus Immat...
ÀͼöÁ¦¾à
ÀϹÝ
±âÈȯ¸íȯ
White Ginseng 9.1 mg, Hoelen 9.1 mg, Cassia Seed 6.07 mg, Gazelle Horn...
±âÈÁ¦¾à
ÀϹÝ
ÇѾçȯ¼Ò´Ü
Lycium Fruit 10.28 mg, Eucommia Bark 10.28 mg, Cornus Fruit 10.28 mg, ...
ûÄèÁ¦¾à
ÀϹÝ
ÇѽÅȯ¼Ò´Ü
Polygala Root 5.14 mg, Lycium Fruit 10.28 mg, Achyranthes Root 5.14 mg...
Çѱ¹½Å¾à
ÀϹÝ
¾Æ·»µåÁ¤5mg
Sodium Alendronate 6.53 mg
ȯÀÎÁ¦¾à
Àü¹®|±Þ¿©
657¿ø/1 °³
¾Æ·»µåÁ¤10mg
Sodium Alendronate 13.05 mg
ȯÀÎÁ¦¾à
Àü¹®|±Þ¿©
1302¿ø/1 °³
´º¸¶±×Á¤
Magnesium Lactate 470 mg, Pyridoxine HCl 5 mg
ȯÀÎÁ¦¾à
ÀϹÝ|±Þ¿©
55¿ø/1 °³
¶óÁ¦ÆÊÁ¤
Flunitrazepam 1 mg
ȯÀÎÁ¦¾à
Àü¹®|±Þ¿©
60¿ø/1 °³
¶ôƾĸ½¶
Lactobacillus Acidophilus Tyndalized Lyophiliazate 170 mg
ȯÀÎÁ¦¾à
ÀϹÝ|±Þ¿©
118¿ø/1 °³
¸®¹öƼÁ¤10mg
Chlordiazepoxide HCl 10 mg
ȯÀÎÁ¦¾à
Àü¹®|±Þ¿©
45¿ø/1 °³
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
case referent study
ȯÀÚ´ëÁ¶±º¿¬±¸
case-control study
ȯÀÚ´ëÁ¶±º¿¬±¸, »ç·Ê´ëÁ¶±º¿¬±¸
case finding program
ȯÀڹ߰߰èȹ, ȯÀڹ߰߻ç¾÷
spot map
ȯÀڹ߻ýÁöµµ
spot mapping
ȯÀڹ߻ýÁöµµÀÛ¼º
flying ambulance
ȯÀÚ¼ö¼ÛºñÇà±â, ±¸±ÞºñÇà±â
air ambulance
ȯÀÚ¼ö¼ÛÇ×°ø±â, ±¸±ÞÇ×°ø±â
stretcher
ȯÀÚ¿î¹ÝÂ÷, µé°Í
patient positioning
ȯÀÚÀ§Ä¡°áÁ¤
patient triggered respirator
ȯÀÚÀ¯¹ß½ÄÈ£Èí±â
patient triggered ventilator
ȯÀÚÀ¯¹ß½Äȯ±â±â
patient identification
ȯÀÚÈ®ÀÎ
auditory hallucination
ȯû, ¼Ò¸®È¯°¢
auditory hallucinosis
ȯûÁõ, ¼Ò¸®È¯°¢Áõ
annelid
ȯÇüµ¿¹°
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
circulator
¼øÈ¯±â
circulatory
¼øÈ¯-
circulatory arrest
¼øÈ¯Á¤Áö
circulatory collapse
¼øÈ¯ÇãÅ»
circulatory congestion
¼øÈ¯¿ïÇ÷
circulatory failure
¼øÈ¯±â´É»ó½Ç, ¼øÈ¯ºÎÀü
circulatory shock
¼øÈ¯¼îÅ©
circulatory system
¼øÈ¯°èÅë, ¼øÈ¯°è
circumferential lamella
µÑ·¹ÃþÆÇ, ȯ»óÃþÆÇ
class switch
Ŭ·¡½ºÀüȯ, Ŭ·¡½º½ºÀ§Ä¡
closed circuit anesthesia
Æó¼â¼øÈ¯¸¶Ãë
collar crown
´ëȯÀÇÄ¡°ü, Ä®¶ó°ü
collateral circulation
°ç¼øÈ¯
command hallucination
¸í·Éȯ°¢
commitment index
³»¿øÈ¯ÀÚÁö¿ªº°±¸¼ºµµ
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
critically ill patient
ÁßȯÀÚ
phantom phenomenon
ÇêÇö»ó, ȯ»óÇö»ó
phantom pain
ÇêÅëÁõ, ȯ»óÅëÁõ
phantom limb pain
Çê´Ù¸®ÅëÁõ, ÇêÆÈÅëÁõ, ȯ»óÁöÅëÁõ
refusion
¼øÈ¯Àç°³
replacement
´ëÄ¡(¼ú), ±³È¯, ġȯ
revolver
ȸÀü±³È¯±â, ȸÀü±â
recirculation
Àç¼øÈ¯
redressement
¹Ýº¹°ÅÁȯ(¼ú)
reduction
1.¸ÂÃã, ±³Á¤, Á¤º¹, 2.ȯ¿ø, Ãà¼Ò
alveolar ventilation rate
ÇãÆÄ²Ê¸®È¯±âÀ², ÆóÆ÷ȯ±âºñ
case morbidity rate
Áõ·ÊÀÌȯÀ²
doctor-patient relationship
ÀÇ»çȯÀÚ°ü°è
morbidity rate
ÀÌȯ·ü
sexual reversion
¼ºÀüȯ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
phantom phenomenon
ȯ»óÇö»ó, ÆÇÅèÇö»ó
pseudopsia
ȯ½Ã
visual hallucination
ȯ½Ã, º¸ÀÓȯ°¢
globulus
ȯ¾à, °ø, ±¸Ã¼, µ¢¾î¸®
reducing sugar
ȯ¿ø´ç
reducing atmosphere
ȯ¿ø´ë±â
reducing substance
ȯ¿ø¹°Áú
reducibility
ȯ¿ø¼º
reducible
ȯ¿ø¼º-
reduction test
ȯ¿ø½ÃÇè
reducing factor
ȯ¿øÀÎÀÚ
reductimetry
ȯ¿øÀûÁ¤
reduction potential
ȯ¿øÀüÀ§
reductant
ȯ¿øÁ¦
reducing agent
ȯ¿øÁ¦, ȯ¿ø½Ã¾à
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
convertase
Àüȯȿ¼Ò
converter
Àüȯ±â, º¯È¯±â
cretin
Å©·¹Æ¾º´È¯ÀÚ
crossingover
±³Â÷, ±³¹è, À¯ÀüÀÚ±³È¯
cryptorchid
Àẹ°íȯ-
cryptorchidectomy
Àẹ°íȯÀýÁ¦(¼ú)
cryptorchidism
Àẹ°íȯÁõ
cryptorchidopexy
(¢¡orchiopexy) °íȯ°íÁ¤¼ú
cryptorchism
(¢¡cryptorchidism) Àẹ°íȯÁõ
cycle
ÁÖ±â, ¼øÈ¯, ȸ·Î, Á֯ļö
cyclic
ÁÖ±â-, ¼øÈ¯-, ȸ·Î-, °í¸®-
cycling
¼øÈ¯¼º
cycloid
¼øÈ¯Çü-
cyclomere
µ¹¸²ºÐÀý, ȯ»óüÀý
cyclosis
¼¼Æ÷Áúȯ·ù
ÀÌÀü
´ÙÀ½
Sponsored Links
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
reduction test
ȯ¿ø½ÃÇè.
reducing factor
ȯ¿øÀÎÀÚ.
reductimetry
ȯ¿øÀûÁ¤(ü½êªîÙïá).
reduction potential
ȯ¿øÀüÀ§.
reducing agent
ȯ¿øÁ¦(ü½êªð¥), ȯ¿ø½Ã¾à.
reductant
ȯ¿øÁ¦(ü½êªð¥).
reduced iron ³ª ferrum reductum
ȯ¿øÃ¶(ü½êªôÑ).
reducible
ȯ¿øÇÒ ¼ö ÀÖ´Â.
reduced hemoglobin
ȯ¿øÇ÷»ö¼Ò(ü½êª úìßäáÈ).
reduced hemoglobin
ȯ¿øÇ÷»ö¼Ò(ü½êªúìßäáÈ)
reduction semiconductor
ȯ¿øÇü¹ÝµµÃ¼(ü½êªû¡ÚâÓôô÷).
reduced flavoprotein
ȯ¿øÇüÇö󺸴ܹéÁú.
reductase
ȯ¿øÈ¿¼Ò
redoxin
ȯ¿øÈ¿¼Ò(ü½êªý£áÈ), ·¹µ¶½Å.
reducase
ȯ¿øÈ¿¼Ò(ü½êªý£áÈ).
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
acute illness policy
±Þ¼ºÁúȯÁ¤Ã¥<--¹æÄ§>
acute infectious disease
±Þ¼º °¨¿°Áúȯ
acute orchitis
±Þ¼º °íȯ¿°
acute rheumatism
±Þ¼º ·ù¸¶Æ¼½ºÁúȯ.
acute transforming virus
±Þ¼º ÇüÁúÀüȯ ¹ÙÀÌ·¯½º
acute transforming virus
±Þ¼ºÇüÁúÀüȯ¹ÙÀÌ·¯½º
acyclia
¼øÈ¯Á¤Áö(âàü»ïÎò).
acyclic compound
ºñȯ»óÈÇÕ¹°.
adenofibroma, of testis
°íȯ ¼±¼¶À¯Á¾
adipose tissue disease
Áö¹æÁ¶Á÷Áúȯ.
admitted patient
ÀÔ¿øÈ¯ÀÚ.
adrenal disorders
ºÎ½ÅÀå¾Ö, ºÎ½ÅÁúȯ.
air borne disease
°ø±â¸Å°³Áúȯ.
air space disease
°ø±â °ø°£ Áúȯ
air-fluid exchange
°ø±â¾×ü±³È¯
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
mesology
ȯ°æÇÐ(Ì·Ḛ̈).
environmental antigen
ȯ°æÇ׿ø
eunuchism
ȯ°üÁõ(ü²Î¯ñø).
ventilation
ȯ±â
ventilatory failure
ȯ±â ºÎÀü
ventilator mode
ȯ±â ¾ç½Ä
ventilation
ȯ±â, Åë±â
ventilation blood flow ratio
ȯ±â-Ç÷·ùºñÀ²(üµÑ¨úìêüÝïëÒ).
ventilation/perfusion ratio
ȯ±â/°ü·ùºñ
ventilation coefficient
ȯ±â°è¼ö(Ì·Ë»ËËà).
overventilation
ȯ±â°úÀ×(üµÑ¨Î¦í¥), °úȯ±â.
tube, ventilating
ȯ±â°ü
ventilating tube
ȯ±â°ü
ventilation perfusion ratio
ȯ±â°ü·ùºñ
ventilation perfusion ratio
ȯ±â°ü·ùºñ.
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
analog to digital converter
¾Æ³ª·Î±× µðÁöÅ» º¯È¯±â
anchor band
À¯Áö´ëȯ(ë«ò¥Óáü»).
anchor clamp band
À¯Áö´ëȯ.
andersen disease
¾Ø´õ½¼º´<--Áúȯ>
anemia,myelophthisic
°ñ¼öġȯ¼º(ÍéâÐöÇüµàõ) (ºóÇ÷)(Þ¸úì)
angiocardiology
1. ½ÉÇ÷°üº´ÇÐ(ãýúìηܻ ùÊ). 2. ¼øÈ¯±âÇÐ(âàü»ÐïùÊ).
angiosis
Ç÷°üÁúȯ(úìηòðü´).
angiospasmodic disease
Ç÷°ü¿¬Ã༺ Áúȯ.
angiotensin converting enzyme
¾ÈÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò.
angiotensin converting enzyme inbibitor
¾ÈÁö¿ÀÅٽŠÀüȯȿ¼Ò ¾ïÁ¦¹°Áú<¾à>.
angiotensin converting enzyme inhibitor
¾ÈÁö¿ÀÅٽŠÀüȯȿ¼Ò ¾ïÁ¦¹°Áú<¾à>.
angiotensin-converting enzyme
¾ÈÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò
anion exchange chromatography
À½À̿±³È¯Å©·Î¸¶Åä±×·¡ÇÇ
anion exchange protein
À½À̿ ±³È¯ ´Ü¹é(ÎßüµÓ±ÛÜ)
anion exchange resin
À½À̿±³È¯¼öÁö
ÀÌÀü
´ÙÀ½
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
Mesorchium
°íȯ°£¸·
[¿¾ ¿ë¾î] °íȯ°£¸·
Rete testis
°íȯ±×¹°
[¿¾ ¿ë¾î] °íȯ(Á¤¼Ò)¸Á
Rete testis
°íȯ±×¹°
[¿¾ ¿ë¾î] °íȯ[Á¤¼Ò]¸Á
Rete testis
°íȯ±×¹°
[¿¾ ¿ë¾î] °íȯ¸Á
Ductulus efferens testis
°íȯ³¯¼¼°ü
[¿¾ ¿ë¾î] °íȯ(Á¤¼Ò)¼öÃâ°ü
Efferent ductules of testis
°íȯ³¯¼¼°ü
[¿¾ ¿ë¾î] °íȯ¼öÃâ°ü
Descent of testis
°íȯ³»¸²
[¿¾ ¿ë¾î] °íȯÇϰ
Septum testis
°íȯ»çÀ̸·
[¿¾ ¿ë¾î] °íȯ(Á¤¼Ò)Áß°Ý
Septum testis
°íȯ»çÀ̸·
[¿¾ ¿ë¾î] °íȯÁß°Ý
Septums of testis
°íȯ»çÀ̸·
[¿¾ ¿ë¾î] °íȯÁß°Ý
Interstitium of testis
°íȯ»çÀÌÁú
[¿¾ ¿ë¾î] °íȯ°£Áú
Interstitium testis
°íȯ»çÀÌÁú
[¿¾ ¿ë¾î] °íȯ[Á¤¼Ò]°£Áú
Lobule of testis
°íȯ¼Ò¿±
[¿¾ ¿ë¾î] °íȯ(Á¤¼Ò)¼Ò¿±
Lobule of testis
°íȯ¼Ò¿±
[¿¾ ¿ë¾î] °íȯ[Á¤¼Ò]¼Ò¿±
Lobules of testis
°íȯ¼Ò¿±
[¿¾ ¿ë¾î] °íȯ¼Ò¿±
ÀÌÀü
´ÙÀ½
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÇÑÀÚ
unformed h.
ºñÁ¤Çüȯ°¢
ÞªïÚû¡ü³ÊÆ
visual h.
º¸ÀÓȯ°¢, ȯ½Ã
ü³ãÊ
¤Ñ cerebrovascular disease
ÃâÇ÷³úÇ÷°üÁúȯ
õóúìÒàúìηòðü´
high positive pressure ventilation
°í¾ç¾Ðȯ±â
ÍÔåÕäâüµÑ¨
¤Ñ vascular disease
°íÇ÷¾ÐÇ÷°üÁúȯ
ÍÔúìäâàõúìηòðü´
¤Ñ arterial occlusive disease
µÎ°³°³»µ¿¸ÆÆó¼â¼º Áúȯ
ÔéËÏË·Ò® ÔÑØæøÍáðàõ òðü´
¤Ñ circulation
µÎ°³°³»¼øÈ¯
ÔéËÏË·Ò® âàü»
inversion
ÀÚ¸®¹Ù²Þ, ¾ÈÂʹøÁü, ³»¹ÝÁõ, ÀüÀ§, Àüȯ
Ò®Úãñû, ï®êÈ, ï®üµ
¤Ñ bone disease
´ë»ç¼º°ñÁúȯ
ÓÛÞóàõÍéòðü´
microcirculation
¹Ì¼¼¼øÈ¯
Ú°á¬âàü»
minute ventilation
ºÐ´çȯ±â·®
ÝÂÓ×üµÑ¨Õá
morbidity (rate)
ÀÌȯ(À²)
ìºü´(ëÒ)
negative
À½¼ºµÇ¸ÔÀ̱â, À½¼º±Íȯ
ëäàõÏýü½
¤Ñ feedback
À½¼º µÇ¸ÔÀ̱â, À½¼º±Íȯ
ëäàõÏýü½
neurodegenerative disease
½Å°æº¯¼ºÁúȯ
ãêÌèܨàõòðü´
ÀÌÀü
´ÙÀ½
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
freeze-substitution
¾ó¸²Ä¡È¯(öÇüµ)
Gaucher's disease
°í¿À¼Å Áúȯ(òðü´)
gene conversion
À¯ÀüÀÚ Àüȯ(ë¶îîíï®üµ)
gene substitution
À¯ÀüÀÚ Ä¡È¯(ë¶îîíöÇüµ)
genetic disease
À¯Àü Áúȯ(ë¶îîòðü´)
Gilbert's disease
±æ¹öÆ® Áúȯ(òðü´)
glycogen storage disease
±Û¶óÀÌÄÚÀü ÀúÀå Áúȯ(îÍíúòðü´)
Hartnup's disease
ÇÏÆ®³Ò Áúȯ(òðü´)
heavy-chain disease
Áß(ñì)»ç½½ Áúȯ(òðü´)
Hers' disease
¿¡¸£½º Áúȯ(òðü´)
Hershey circle
Çã½Ãȯ(ü»)
hydrogen exchange
¼ö¼Ò ±³È¯(â©áÈÎßüµ)
hydrogen iostope exchange
¼ö¼Ò µ¿À§¿ø¼Ò ±³È¯(â©áÈÔÒêÈêªáÈÎßüµ)
I-cell disease
I-¼¼Æ÷ Áúȯ(á¬øàòðü´)
immune deficincy disease
¸é¿ª °áÇÌ Áúȯ(Øóæ¹ÌÀù¹òðü´)
ÀÌÀü
´ÙÀ½
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
fantasy
°ø»ó, ȯ»ó
fast Fourier transform
°í¼ÓFourierº¯È¯
feedback
µÇ¸ÔÀ̱â, ±Íȯ
fetal circulation
žƼøÈ¯, žÆÇ÷Çà
focal disease
ÃÊÁ¡¼ºÁúȯ
Fourier transform [=FT]
Fourierº¯È¯
glycogen storage disease
±Û¸®ÄÚ°Õ ÃàÀûÁúȯ
granule
°ú¸³, ȯ¾à
granulomatous disease
À°¾ÆÁ¾¼ºÁúȯ
hematopoietic disease
Á¶Ç÷¼ºÁúȯ
Henle's loop
Çﷹȯ, Çî·¹°èÁ¦, Çî·¹°í¸®, ¼¼´¢°ü°èÁ¦
hyperperfusion
°ú¼øÈ¯
hypertensive vascular disease
°íÇ÷¾Ð¼ºÇ÷°üÁúȯ
hyperventilation
°úȯ±â, ȯ±âÇ×Áø, È£ÈíÇ×Áø, °úÈ£Èí
hypothalamic disorder
½Ã»óÇϺÎÁúȯ
ÀÌÀü
´ÙÀ½
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
5
ÆäÀÌÁö:
5
ÄÚµå
¿µ¹®
ÇѱÛ
B25.8
Other cytomegaloviral diseases
±âŸ °Å´ë¼¼Æ÷¹ÙÀÌ·¯½º Áúȯ
B26.0+
Mumps orchitis)(N51.1 *
º¼°Å¸® °íȯ¿°
B33
Other viral diseases, NEC
´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº ±âŸ ¹ÙÀÌ·¯½º Áúȯ
B33.8
Other specified viral diseases
±âŸ ¸í½ÃµÈ ¹ÙÀÌ·¯½º Áúȯ
B60
Other protozoal diseases, NEC
´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº ±âŸ ¿øÃæÁúȯ
ÀÌÀü
´ÙÀ½
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
¼³¸í
patient exposure
ȯÀÚ ³ëÃâ
case control study
ȯÀÚ ´ëÁ¶ ¿¬±¸
case finding program
ȯÀÚ ¹ß°ß °èȹ, ȯÀÚ ¹ß°ß »ç¾÷
patient protection
ȯÀÚ ¹æ¾î
air ambulance
ȯÀÚ ¼ö¼Û ºñÇà±â
patient charting
ȯÀÚ ÃÆ® ÀÛ¼º
ȯÀÚÀÇ Áø´Ü ¹× Ä¡·á¿¡ ÇÊ¿äÇÑ ÀûÀýÇÑ Á¤º¸¸¦ ±â·Ï, ÀÛ¼ºÇÏ´Â °Í.
patient identification
ȯÀÚ È®ÀÎ
between-patient variability
ȯÀÚ°£ º¯È
patient's expectation
ȯÀÚÀÇ ±â´ë
patient coping style
ȯÀÚÀÇ ´ëó ¾ç½Ä
patient's perception
ȯÀÚÀÇ ÀÎÁö
patient's compliance
ȯÀÚÀÇ ÀûÀÀ
pilula
ȯÁ¦, ȯ¾à
acouasm
ȯû
acousma
ȯû
»ó»óÀÇ À½.
ÀÌÀü
´ÙÀ½
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
¼³¸í
case control study
ȯÀÚ ´ëÁ¶ ¿¬±¸
case finding program
ȯÀÚ ¹ß°ß °èȹ, ȯÀÚ ¹ß°ß »ç¾÷
casual
¿ì¹ß¼ºÀÇ, ±¸±Þ ȯÀÚ
¿ì¹ß¼ºÀÇ, º´¿ø ±¸±Þ ħ´ë¿¡ Àִ ȯÀÚ.
cation exchanger
¾ç À̿ ±³È¯Ã¼
CDA certified dentual assistantÀÇ ¾àÀÚ.
CDC
Áúȯ Á¶Àý ¹× ¿¹¹æ ¼¾ÅÍ
Centers for Disease Control and PreventionÀÇ ¾àÀÚ.
cell substitution
¼¼Æ÷ ġȯ, Ç÷±¸ Àç»ý
chart
ȯÀÚ ±â·ÏÁö, µµÇ¥, ÇØµµ, º´·ÂÁö
¾î¶² º¯¼ö, ¿¹ÄÁ´ë ¸Æ¹Ú, ü¿Â, È£Èí¼ö º¯µ¿ µîÀÇ ´Ü¼øÈµÈ ±×¸² Ç¥½Ã, ¶Ç´Â ƯÁ¤ÇÑ Áõ·Ê ÀüüÀÇ ÀÓ»ó ¼Ò°ßÀÇ ±â·Ï.
chemical environment
ÈÇРȯ°æ
chop amputation
Æò¸é ȯ»ó Àý´Ü
chromesthesia
»ö ȯ°¢
½ÇÁ¦ÀÇ Ã»°¢, ¹Ì°¢, Èİ¢¿¡ ¼ö¹ÝÇÏ¿© ÀϾ´Â »öäÀÇ È¯°¢.
chromophose
»ö°¨ ȯ°¢, ÁÖ°üÀû »ö°¢
cicumcision
ȯ»ó ÀýÁ¦¹ý
circular
ȯ»ó, À±»ó
circular chromosome
ȯ»ó ¿°»öü
circular insanity
¼øÈ¯ Á¤½Å ÀÌ»ó
ÀÌÀü
´ÙÀ½
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú:
10
ÆäÀÌÁö:
5
Ä«µð¾ÆÁªÁ¤90mg
A09701951
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Diltiazem HCl
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
ȯÀÎÈ÷´ÜÅäÀÎÁ¤100mg
A09700941
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Phenytoin
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
µ¶½ÃÄÚ¸°Á¤
A09702671
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Doxycycline hyclate
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | »èÁ¦
¿¡¸£´úÁøÁ¤1.5mg
A09701151
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Ergoloid Mesylate
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
¿¡¸£´úÁøÁ¤1mg
A09701381
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Ergoloid Mesylate
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
¶óÁ¦ÆÊÁ¤
G01000221
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Flunitrazepam
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
Æø¼¼Æ¾Ä¸½¶20mg
A09703591
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Fluoxetine HCl
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
Ǫ·Îźİ¼¿
A09703381
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Fursultiamine HCl, Hydroxocobalamin acetate, Pyridoxal phosphate, Riboflavin
±¸ºÐ/º¸Çè±Þ¿©: ÀϹÝÀǾàǰ | ¹Ì»ý»ê
Æä¸®µ¹Á¤1.5mg
A09701311
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Haloperidol
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
Æä¸®µ¹Á¤10mg
A09701521
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Haloperidol
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
ÀÌÀü
´ÙÀ½
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ventilate
ȯ±â¸¦ ÇÏ´Ù
ventilator
ȯ±âÀåÄ¡
ventilate
ȯ±âÇÏ´Ù;(Ç÷¾×À») ½Å¼±ÇÑ °ø±â·Î Á¤ÈÇÏ´Ù;ȯ±â ÀåÄ¡¸¦ ´Þ´Ù;(¹®Á¦¸¦)°øÇ¥ÇÏ´Ù;ÀÚÀ¯·Ó°Ô Åä·ÐÇÏ´Ù
annulus
ȯ´ë
hospitality
ȯ´ë
Collins
ȯ´ë¿¡ ´ëÇÑ ÀλçÀå;ÁøÀ» ź À½·á(ĬÅ×ÀÏÀÇ ÀÏÁ¾)
hospitable
ȯ´ëÇÏ´Â
regale
ȯ´ëÇÏ´Ù; ¼ºÂùÀ» ¸Ô´Ù
magic lantern
ȯµî
magic lantern
ȯµî±â(¿À´Ã³¯ÀÇ projector)
phantasmagoria
ȯµîÀÇ ÀÏÁ¾;ÁÖ¸¶µî °°Àº ±¤°æ
conviviality
ȯ¶ô
merrymaking
ȯ¶ô;¼úÀÜ
mirth
ȯ¶ô;À¯Äè;¸í¶û
Cockaigne
ȯ¶ô°æ;·±´ø
ÀÌÀü
´ÙÀ½
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
pastime
¿À¶ô, ±âºÐÀüȯ, ¼ÒÀϰŸ®
patient
Àγ»½ÉÀÌ °ÇÑ,ȯÀÚ
phantasm
ȯ»ó
phantasmic
ȯ¿µÀÇ
pilular
ȯ¾àÀÇ
pilulous
ȯ¾àÀÇ
rapture
ȯÈñ
recession
¹Ýȯ
reciprocate
±³È¯ÇÏ´Ù; º¸´äÇÏ´Ù
reciprocation
±³È¯
recreation
±âºÐ Àüȯ
recurrence
¹Ýº¹, ¼øÈ¯
recycle
Àç¼øÈ¯ÇÏ´Ù; Àç°¡°øÇÏ´Ù
refection
±âºÐÀüȯ; ÈÞ¾ç
regale
ȯ´ëÇÏ´Ù; ¼ºÂùÀ» ¸Ô´Ù
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
ÀÌÀü
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú:
0
ÆäÀÌÁö:
5
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½